J. Hegde

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
John V Hegde, John Hegde, J.v. Hegde, J V Hegde, John V. Hegde
Publication record
83 papers · 1,428 citations · H-index 17

PAPERS

Dose-escalated stereotactic body radiotherapy re-irradiation in patients with recurrent head and neck cancer: a prospective phase 2 study using automated non-coplanar volumetric modulated arc therapy.
20250 citationsauthor #7
Patient-reported quality of life and adherence outcomes after integrating exclusive liquid meal replacement in patients with head and neck cancer undergoing chemoradiation: results from a phase II study
20250 citationsauthor #13
Results of an AI-Based Image Review System to Detect Patient Misalignment Errors in a Multi-Institutional Database of CBCT-Guided Radiotherapy Treatments.
20240 citationsauthor #5
Retrospective examination of pseudoprogression in IDH mutant gliomas
20233 citationsauthor #10
Seizure outcomes following single-fraction versus hypofractionated radiosurgery for brain metastases: a single-center experience.
20232 citationsauthor #8
Experience of Telemedicine Visits in Radiation Oncology During the COVID-19 Pandemic: A US National Survey and Lessons Learned for Incorporating Telemedicine Post-COVID-19
20226 citationsauthor #6
A Prospective Phase II Study of Automated Non-Coplanar VMAT for Recurrent Head and Neck Cancer: Initial Report of Feasibility, Safety, and Patient-Reported Outcomes
202215 citationsauthor #8
Radiation Therapy for Mantle Cell Lymphoma with Orbital Involvement.
20221 citationsauthor #6
Prostate-Centric Versus Bony-Centric Registration in the Definitive Treatment of Node-Positive Prostate Cancer with Simultaneous Integrated Boost: A Dosimetric Comparison
20222 citationsauthor #6
Simultaneous radiosurgery for multiple brain metastases: technical overview of the UCLA experience
202120 citationsauthor #5
High-Dose Rate Interstitial Spine Brachytherapy Using an Intraoperative Mobile Computed Tomography-Guided Surgical Navigation System
20213 citationsauthor #7
Patient-Reported Quality of Life Outcomes After Integrating Exclusive Liquid Meal Replacement in Patients With Head and Neck Cancer Undergoing Chemoradiation: Results From a Phase II Study.
20210 citationsauthor #11
Automated Non-Coplanar VMAT for Dose Escalation in Recurrent Head and Neck Cancer Patients
202123 citationsauthor #6
Ventilation measurements using fast‐helical free‐breathing computed tomography
20213 citationsauthor #7
A Framework for Sharing Radiation Dose Distribution Maps in the Electronic Medical Record for Improving Multidisciplinary Patient Management.
20218 citationsauthor #7
Prostate-Centric vs. Bony-Centric Registration in the Definitive Treatment of Node-Positive Prostate Cancer With Simultaneous Integrated Boost: A Dosimetric Comparison.
20210 citationsauthor #6
A Practical Guide for Navigating the Design, Build, and Clinical Integration of Electronic Patient-Reported Outcomes in the Radiation Oncology Department.
20218 citationsauthor #5
Clinical Outcomes of Single-Isocenter Versus Multiple-Isocenter Stereotactic Radiosurgery Techniques for Multiple Brain Metastases.
20211 citationsauthor #16
Simultaneous radiosurgery for multiple brain metastases: technical overview of the UCLA experience
20210 citationsauthor #5
Telemedicine Perspectives in Radiation Oncology
20210 citationsauthor #5
Locoregional Management of Inflammatory Breast Cancer
20205 citationsauthor #2
Single-Isocenter, Multi-Metastasis, Linear Accelerator-Based Stereotactic Radiosurgery For Multiple Brain Metastases
20200 citationsauthor #17
Resilience vs. Vulnerability: Psychological Safety and Reporting of Near Misses
20200 citationsauthor #4
Targeted radiation: Specificity and deescalation
20200 citationsauthor #4
Incident Learning System Offers a Non-interpersonal Platform to Speak Up
20200 citationsauthor #3
The Timeliness Initiative: Continuous Process Improvement for Prompt Initiation of Radiation Therapy Treatment
202014 citationsauthor #7
RADT-12. DISEASE CHARACTERISTICS IN ACUTE SEIZURE FOLLOWING RADIOTHERAPY FOR BRAIN METASTASES
20200 citationsauthor #11
Factors Associated with Early Termination of Palliative Radiotherapy in a Hospitalized Patient Cohort
20200 citationsauthor #9
Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis.
202021 citationsauthor #24
Logistical Assessment of Palliative Radiotherapy Workflow for Hospitalized Patients at a Single Academic Institution
20200 citationsauthor #8
Resilience vs. Vulnerability: Psychological Safety and Reporting of Near Misses with Varying Proximity to Harm in Radiation Oncology.
202023 citationsauthor #4
Missing the Near Miss: Recognizing valuable learning opportunities in radiation oncology.
20207 citationsauthor #6
Time-driven activity based costing comparison of stereotactic radiosurgery to multiple brain lesions utilizing single-isocenter vs. multiple-isocenter technique.
201910 citationsauthor #6
Integrating Exclusive Liquid Meal Replacement Supplementation to Reduce Gastrostomy Tube Rates in Patients with Head and Neck Cancer Undergoing Chemoradiation: Preliminary Results of a Phase II Study
20190 citationsauthor #1
Patient perspectives and treatment regret after de‐escalated chemoradiation for human papillomavirus‐positive oropharyngeal cancer: Findings from a phase II trial
201910 citationsauthor #2
Potential Impact of 68Ga-PSMA-11 PET/CT on the Planning of Definitive Radiation Therapy for Prostate Cancer
201897 citationsauthor #10
68Ga-PSMA PET/CT Mapping of Prostate Cancer at Initial Staging: Potential Impact on Definitive Radiation Therapy Planning
20180 citationsauthor #5
Patient‐reported quality‐of‐life outcomes after de‐escalated chemoradiation for human papillomavirus‐positive oropharyngeal carcinoma: Findings from a phase 2 trial
201827 citationsauthor #1
The patient's perspective on breast radiotherapy: Initial fears and expectations versus reality
201846 citationsauthor #3
The Association of Canonical Speech- and Swallow-Related Dosimetric Constraints with Patient-Reported Quality of Life Outcomes: Results from a Phase II Trial of Dose De-Escalated Chemoradiation for HPV-Associated, Locally-Advanced Oropharyngeal Carcinoma
20180 citationsauthor #1
Head and neck cancer reirradiation with interstitial high‐dose‐rate brachytherapy
201814 citationsauthor #1
Respiratory motion-resolved, self-gated 4D-MRI using Rotating Cartesian K-space (ROCK): Initial clinical experience on an MRI-guided radiotherapy system.
201819 citationsauthor #8
Magnetic Resonance Imaging Guidance Mitigates the Effects of Intrafraction Prostate Motion During Stereotactic Body Radiotherapy for Prostate Cancer
20187 citationsauthor #1
Accelerated 3D bSSFP imaging for treatment planning on an MRI‐guided radiotherapy system
201813 citationsauthor #6
Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer
2018285 citationsauthor #25
Development and Implementation of an Interprofessional Curriculum for Radiation Oncology Nursing Staff
20180 citationsauthor #4
Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer
20178 citationsauthor #1
68 Ga-PSMA PET/CT Mapping of Early Biochemical Recurrence (PSA <1 ng/mL) After Primary Surgery in 270 Patients: Impact on Salvage Radiation Therapy Planning
20170 citationsauthor #11
Advances in Radiation Oncology: What to Consider.
20178 citationsauthor #1
Abstract P3-02-07: Predictors associated with MRI surveillance screening in women with a personal history of unilateral breast cancer but without a genetic predisposition for future contralateral breast cancer
20170 citationsauthor #1
Factors Associated With MRI Screening in Women With a Personal History of Invasive, Unilateral Breast Cancer Predominately Encompass Detectability Concerns Rather Than Future Breast Cancer Risk
20170 citationsauthor #1
68Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning
2017252 citationsauthor #5
Prostate Cancer Antigen 3 Score Does Not Predict for Adverse Pathologic Features at Radical Prostatectomy or for Progression-free Survival in Clinically Localized, Intermediate- and High-risk Prostate Cancer.
20175 citationsauthor #1
Prostate Cancer Antigen 3 Score Does Not Predict for Adverse Pathologic Features at Radical Prostatectomy or for Progression-Free Survival in Intermediate- and High-Risk Prostate Cancer
20170 citationsauthor #1
Imaging and Pathology Correlations for Different Risk Stratification Models for Intermediate-risk Prostate Cancer.
20171 citationsauthor #2
Pre-Treatment MRI Staging Predicts for Biochemical Failure in High-Risk Prostate Cancer Treated with Combination High-Dose-Rate Brachytherapy and External Beam Radiotherapy
20172 citationsauthor #1
Patient perspectives and treatment regret after de-escalated chemoradiotherapy for HPV-positive head and neck cancer: Findings from a phase II trial.
20170 citationsauthor #2
Pretreatment 3T multiparametric MRI staging predicts for biochemical failure in high-risk prostate cancer treated with combination high-dose-rate brachytherapy and external beam radiotherapy.
201723 citationsauthor #1
(P074) Patient-Reported Quality of Life Outcomes After De-Escalated Chemoradiation for HPV-Positive Oropharyngeal Carcinoma: Findings From a Phase II Trial
20172 citationsauthor #1
Functional Outcomes after De-escalated Chemoradiation for Human Papillomavirus-Positive Oropharyngeal Cancer: Findings from a Phase 2 Trial
20170 citationsauthor #1
Predictors associated with MRI surveillance screening in women with a personal history of unilateral breast cancer but without a genetic predisposition for future contralateral breast cancer
20171 citationsauthor #1
Juxtapapillary and circumpapillary choroidal melanoma: globe-sparing treatment outcomes with iodine-125 notched plaque brachytherapy
201717 citationsauthor #1
The Patient's Perspective on Breast Radiation Therapy: Initial Fears and Expectations Versus Reality
20171 citationsauthor #3
Functional Outcomes After De-escalated Chemoradiation Therapy for Human Papillomavirus-Positive Oropharyngeal Cancer: Secondary Analysis of a Phase 2 Trial.
201712 citationsauthor #1
Establishing the distribution of satellite lesions in intermediate- and high-risk prostate cancer: implications for focused radiotherapy
20178 citationsauthor #1
Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study.
201717 citationsauthor #24
Multidisciplinary Breast Clinic: Impact on Pretreatment Evaluation, Timeliness, and Guideline Concordant Care
20160 citationsauthor #2
Contralateral Breast Cancer Risk and the Selection of Contralateral Prophylactic Mastectomy Among Women With Unilateral Breast Cancer
20161 citationsauthor #1
The significance of PTV dose coverage on cancer control outcomes in early stage non-small cell lung cancer patients treated with highly ablative stereotactic body radiation therapy.
201620 citationsauthor #5
Do Current Clinical Risk Stratification Models for Intermediate-Risk Prostate Cancer Patients Actually Predict for Unfavorable Pathological Features on Radical Prostatectomy Specimens?
20160 citationsauthor #2
Does the addition of targeted prostate biopsies to standard systemic biopsies influence treatment management for radiation oncologists?
20168 citationsauthor #2
How we used a patient visit tracker tool to advance experiential learning in systems-based practice and quality improvement in a medical student clinic
20169 citationsauthor #3
A Pooled Analysis of Biochemical Failure in Intermediate-risk Prostate Cancer Following Definitive Stereotactic Body Radiotherapy (SBRT) or High-Dose-Rate Brachytherapy (HDR-B) Monotherapy
201618 citationsauthor #1
Establishing Predictors of Satellite Lesions in Men With Intermediate- and High-Risk Prostate Cancer for Improved Patient Selection for Focal and Focused Therapy
20160 citationsauthor #1
Clinical Outcomes With Image Guided, Notched Eye Plaque Brachytherapy for Papillary Choroidal Melanoma
20150 citationsauthor #1
Is the PTV Margin Important for Local Control in Stage I Non-Small Cell Lung Cancer (NSCLC) Patients Treated With Definitive SBRT?
20150 citationsauthor #4
Maximum tumor diameter and the risk of prostate-specific antigen recurrence after radical prostatectomy.
20145 citationsauthor #7
MP46-14 MAXIMUM TUMOR DIAMETER AND THE RISK OF PSA FAILURE AFTER RADICAL PROSTATECTOMY
20140 citationsauthor #7
The effect of differing Gleason scores at biopsy on the odds of upgrading and the risk of death from prostate cancer.
20144 citationsauthor #9
Preoperative 3-Tesla multiparametric endorectal magnetic resonance imaging findings and the odds of upgrading and upstaging at radical prostatectomy in men with clinically localized prostate cancer.
201356 citationsauthor #1
Detecting lower in addition to the highest Gleason score prostate cancer on core biopsy and the odds of upgrading at radical prostatectomy.
20131 citationsauthor #7
Multiparametric MRI of prostate cancer: An update on state‐of‐the‐art techniques and their performance in detecting and localizing prostate cancer
2013250 citationsauthor #1
Preoperative 3-Tesla multiparametric endorectal MRI findings and the odds of upgrading and upstaging at radical prostatectomy in men with clinically localized prostate cancer
20125 citationsauthor #1

TIMELINE

2012 5 citations

2013 307 citations

2014 9 citations

2015 0 citations

2016 56 citations

2017 357 citations

2018 508 citations

2019 20 citations

2020 70 citations

2021 66 citations

2022 24 citations

2023 5 citations

2024 0 citations

2025 0 citations

J. Hegde

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT